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ABSTRACT: Increases in minute ventilation (V'E) have been observed during 
exacerbations of asthma and in response to administration of histamine. However, 
it is not yet clear how the breathing pattern is affected, and whether the increase 
in V'E is found in general.
In the present study, the effects of inhalation of histamine on respiratory fre­
quency ( fR ) ,  tidal volume ( F t ) ,  V'e, and on functional residual capacity (FRC) 
were evaluated in 63 humans. Forty four subjects were hyperresponsive (BHR+). 
In each of these subjects, the doses of histamine applied for the present study 
(mean 3.5 mg-mLr1) caused a decrease in forced expiratory volume in one second 
(FEVi) that was greater than 20% of the control value. The dose of histamine 
applied in the 19 nonhyperresponsive subjects (BHR-) was substantially larger (8.0 
mg-mL1) whilst for this dose the decrease in FEVi was less than 20% of control 
value.
Alter histamine, ƒ R was significantly increased in both subgroups of subjects, 
BHR+ and BHR-. The increase in V'E was significant in BHR- but not significant 
in BHR+. In general, the changes in V'E,/R and Vt were not uniform; compara­
ble numbers of subjects responded with increases (n«33) and decreases (n=30) in 
V'e. For /R  40 subjects responded with an increase and 23 with a decrease, and 
for Vt these numbers were 26 and 37, respectively. The increase in FRC after his­
tamine was significantly larger in BHR+ subjects than in BHR-.
These findings may be interpreted to indicate that different mechanisms with 
opposite effects may be operating simultaneously, e.g. excitation of central inspi­
ratory activity by stimulation of rapidly-adapting pulmonary stretch receptors, 
which will promote increases in respiratory frequency, tidal volume and minute 
ventilation, and bronchoconstriction with increased airway resistance, which will 
promote decreases in these parameters. As a consequence, depending on the net 
result of these opposite contributions to, e.g. minute ventilation, administration of 
histamine will cause an increase in minute ventilation in one subject and a decrease 
in another.
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Bronchoconstriction and hyperventilation occur dur­
ing exacerbations of asthma. Generally, arterial carbon 
dioxide tension (Pa,C0 2) does not change, or even decrea­
ses during exacerbations of asthma, indicating that ven­
tilation must have increased [1, 2]. It has been known 
for years that patients with asthma hyperventilate when 
acutely ill [3-5]. It has also been found that minute 
ventilation (V'E) increases in response to progressive 
methacholine-induced and histamine-induced broncho­
constriction [5-9]. Other studies, however, have indica­
ted that inhaled histamine or methacholine may result 
in a rapid, sometimes shallow, breathing pattern [10], 
or that the breathing pattern is not changed in response 
to histamine or methacholine [11, 12]. Thus, results on 
ventilatory responses to induced bronchoconstriction 
reported in the literature are not consistent. Strom berg 
and G ustafsson  [13] found that, during a histamine 
challenge, 4 out of 8 patients responded with an increase 
in V'E, whereas V'e was unchanged or tended to decre­
ase in the remaining patients. These authors suggested 
that the latter patients were "ventilatory nonresponders".
Recently, it has been shown, in a selected group of
patients with asthma, that during histamine challenge 
tests changes in breathing pattern occur prior to changes 
in the forced expiratory volume in one second (FEVi) 
[14]. This finding suggests that the increase in airway 
resistance does not play the only role in the change in 
pattern of breathing, and, furthermore, that vagal air­
way receptors may be involved by direct stimulation. It 
is well-known that pulmonary receptors influence the 
breathing pattern [15, 16]. The duration of inspiration 
(tl) is controlled mainly by slowly-adapting stretch re­
ceptors (SARs) through the off-switch mechanism, and, 
at least in part, duration of expiration (fE) is determined 
by rapidly-adapting stretch receptors (RARs) [17-19]. In 
a previous study in cats, we found that respiratory freq­
uency (fR) increased significantly (p<0.01) in response 
to stimulation of RARs by intravenous administration 
of histamine [20]. During mechanical stimulation of 
RARs by continuous negative airway pressure, an incre­
ase in f R  was also found [21]. RARs can be stimulated 
by histamine in two ways: mechanically (by broncho­
constriction) and chemically [22-25].
Functional residual capacity (FRC) may increase after
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administration of histamine. This is due to the concom­
itant broncho constriction and/or an increase in end-tidal 
inspiratory activity (ETIA) [26]. Changes in FRC may 
indirectly influence the breathing pattern because of 
the relationship between lung volume and the activity 
of pulmonary stretch receptors. Furthermore, an incre­
ase in FRC may limit the increase in Vr.
It is not yet clear how the breathing pattern changes 
during exacerbations of asthma and induced broncho- 
constriction. The aims of the present study, therefore, 
were: 1) to evaluate the effects of administration of his­
tamine on the breathing pattern and on FRC in humans; 
and 2) to evaluate whether the degree of bronchial respon­
siveness plays a role in histamine-induced changes in
V ’E.
M ethods
Subjects
Sixty three subjects participated in this study. Charac­
teristics of the subjects are presented in table 1. Bron- 
chodilators were withheld for at least 8 h prior to the 
study. In a standardized histamine challenge test, the 
provocative concentration of histamine which caused a 
fall of >20% in FEVi (PC20) [27, 28] was determined. 
To shorten the duration of the test, the starting concen­
tration of histamine varied depending on the response 
to an aerosol of saline, and medication requirements [28- 
30]. A histamine concentration of 8 mg-ml/ 1 was used 
as the upper limit of the test. Forty four subjects show­
ed bronchial hyperresponsiveness (PC20 <8 mg-rnL'1) 
("BHR+"). The remaining 19 subjects were not hyper- 
responsive (MBH R-,r). Informed consent was obtained 
from all subjects. The subjects were naive with respect 
to the scientific goals of the study. The study was appro­
ved by the hospital Medical Ethics Committee.
Experimental set-up
Aerosols were generated by a DeVilbiss 646 je t nebu­
lizer (Devilbiss Co., Somerset, PA, USA. The calibrated 
output of the nebulizer was 0.13 mL-min“1. The hista­
mine concentration that was used in the further experi-
Table 1. -  Characteristics of subjects
Total BHR+ BHR-
S ubj ects n 63 44 19
Sex M/F 29/34 21/23 8/11
Age yrs 34±2 35±2 34±2
Height cm 173±1 172±1 175±2
Histamine mg-rnL' 1 4.8±0.44 3.5±0.50 8.0±0.0***
FEVl % pred control 92±2 87±2 103±3***
histamine 70±3### 60±2### 93±3i###***
Data are presented as absolute number or as mearttsEM. % 
pred: percentage of predicted value; M: male; F: female; 
FEV1: forced expiratory volume in one second; BHR+: hyper- 
responsive; BHR-: nonhyperresponsive. Note that the con­
centration of histamine administered to the subgroup of subjects 
with BHR- was about twice that administered to the subgroup 
of subjects with BHR+. m \ p<0.001, compared to control val­
ues; ***: p<0.001, compared to BHR+ values.
Fig. 1. -  Diagram of breathing circuit. 1: subject connected to cir­
cuit by mouthpiece; 2: soda lime; 3: port for supplying 0 2; 4: blow­
er for bias flow; 5: wedge spirometer; 6 : 0 2 analyser; 7: nebulizer; 
8 : blower generating flow for aerosol. The dead space of the circuit 
was 49 mL,
ments depended on the individual result of the histamine 
challenge protocol. In BHR+ subjects, ventilatory para­
meters were studied at the PC20 dose. In BHR- subjects, 
the ventilatory parameters were studied at a histamine 
dose of 8 mg-rnL"1.
FEVl and FVC were measured by a pneumotacho­
graph (Fukuda Sangyo, Tokyo, Japan). Changes (A) in 
FRC, f R  tidal volume (Vt) and V'E were calculated from 
the spirograms recorded before and after inhalation of 
histamine. Two methods were applied to record these 
spirograms: 1) using a wedge spirometer in a closed brea­
thing circuit; and 2) using respiratory inductive plethys­
mography (RIP) (Respitrace®; Respitrace Ca, Ardsley, 
USA). Values were related to the reference values of the 
European Respiratory Society [31].
Forty one subjects (29 BHR+ and 12 BHR-) were 
connected to the closed breathing circuit by a mouth­
piece. A blower maintained a constant bias flow in the 
circuit (120 L-min*1). Gas was sampled continuously from 
the circuit for measurement of the oxygen concentra­
tion (Taylor Servomex, Sussex, UK), and subsequently 
fed back into the system (fig. 1). Oxygen was supplied 
to maintain a constant oxygen concentration (21%) in 
the circuit. Exhaled C 0 2 was absorbed by soda lime. A 
mismatch between 0 2 supply and 0 2 uptake by the sub­
ject would cause the baseline of the spirometer signal 
to drift one way or the other, which would affect the 
result for AFRC. The shift of the baseline of the spiro­
meter signal (AV) is proportional to the deviation of the
0 2 concentration (ACo2) from 21%. The relationship 
between A V  and ACo2 was determined experimentally 
by adding a known amount of pure oxygen to the sys­
tem and reading the corresponding change in Co2. With 
the help of this relationship, we have corrected the raw 
data for AFRC for the aforementioned Correlated shift 
of the baseline of the spirometer signal. The inaccura­
cy of the correction was ±6 mL. This error adds to the 
overall random error in the determination of AFRC. The 
DeVilbiss 646 jet nebulizer was connected to the cir­
cuit near the mouthpiece (fig. 1).
The remaining subjects (15 BHR+ and 7 BHR-) were 
connected to the RIP system and via a mouthpiece to 
the nebulizer. The RIP was used in the direct current 
(DC)-mode. Volume calibration of the Respitrace was 
performed with a spirometer (Hospal, Littleton, CO,
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USA), just prior to the administration of the aerosol of 
histamine, and immediately after the recording had been 
ended while the subject was still sitting in the same 
position. If the two calibration factors differed by more 
than 10%, the measurement was excluded from the 
study. Thus, for each subject, a conversion factor was cal­
culated from the lung volume changes measured with 
the spirometer and the associated deflections obtained 
from the RIP.
The spirograms were recorded with a multichannel 
X-t recorder (Kip, The Netherlands) for off-line analy­
sis of the changes in V'e, VT, f R  and FRC. All subjects 
were tested in the sitting position, whilst breathing thro­
ugh the mouthpiece with the nose clipped. When the 
subjects were seated in a relaxed posture, they were 
asked to remain seated in that way until the end of the 
recording. Thus, with the co-operation of the subjects, 
we were able to minimize the impact of postural mus­
cles on the volume changes recorded. To divert their 
attention from breathing, the subjects were asked to con­
centrate on a poster placed in front of them.
Table 2. -  Effects of aerosolized histamine on breath­
ing pattern
Total BHR+ BHR-
Subjects n 63 44 19
V'E L-mhr1 control 8.1±0.4 8.3*0.4 7.8±0.7
histamine 8.7*0.4 8,6*0.5 8.8*0.8#
f R  breaths-min-1 control 16.3±0.7 17.1*0.8 14.3*1.2
histamine 17.8*0.8*18.6*1.0# 15.9*1.5#
Vt mL control 524*21 496*19 589*49*
histamine 514*21 479*21 595*46*
AFRC % pred 8*1 9.9*13 4.1*1.0**
AFRC mL 256*31 312*40 128*33**
Data are presented as mean±SEM for all subjects (total), sub­
jects with hyperresponsiveness (BHR+) and subjects without 
hyperresponsiveness (BHR-). A: changes relative to control; 
V*E: minute ventilation; / r :  respiratory frequency; VT: tidal 
volume; FRC: functional residual capacity. *: p<0,05, com­
pared to  BHR+; **: p<0.01, compared to BHR+; p<0.05 
compared to control value; ###: p<0 .001, compared to control 
value.
Experimental protocol
Recording was started after the subjects had been con­
nected to the mouthpiece. The uninterrupted recording 
included control breaths, breaths during the period of 2 
min of inhalation of histamine, and for at least 1 min 
following inhalation of histamine. FEVi and FVC were 
measured immediately before this recording, and 1.5 
min after inhalation of histamine had been stopped.
Statistical analysis
From each recording, two sets of values for ƒ&, VT, 
and V'e were calculated from five consecutive control 
breaths just prior to the inhalation of histamine, and 
from five consecutive breaths 1 min after inhalation of 
histamine, respectively. The AFRC was calculated from 
the shift in the baseline of the spirometer signal between 
these two groups of breaths.
Differences between the results before (control) and 
after inhalation of histamine, and differences between 
the results of the two groups (BHR+ and BHR-) were 
evaluated for statistical significance using the t-test for 
paired observations and the t-test for unpaired observa­
tions, respectively. A p-value of less than 0.05 was con­
sidered to be significant.
Results
The characteristics of the subjects are presented in 
table 1. Sex, age and height were not significantly dif­
ferent between BHR+ and BHR-. For BHR+, BHR- and 
the group as a whole, FEVl decreased significantly in 
response to the dose of histamine applied as compared 
with control values. The mean concentration o f  hista­
mine administered to BHR+ (3.5 m g-m l/1) was less 
than half of that administered to BHR- (8.0 m g -m l/1)- 
Nonetheless, the decrease in FEVl in BHR+ was con­
siderably larger than that in BHR-.
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Fig. 2. -  a) Relationship between change in minute ventilation 
(A V’E) and change in forced expiratory volume in one second (AFEVi) 
in response to histamine in 44 subjects with hyperresponsiveness 
(BHR+) and 19 subjects without hyperresponsiveness (BHR-). AFEVl 
is expressed as percentage change from control values. For BHR+ 
(r=-0.319; p<0.05); for BHR- (r=-0.012; p=Ns); for whole group (r=- 
0.273; p<0.05). b) Relationship between A V'e and histamine concen­
tration in 44 BHR+ and 19 BHR-. For whole group (r=0.117; p=Ns), 
o: BHR+; a: BHR-. ns: nonsignificant.
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Ventilatory responses to inhalation of histamine deter­
mined with the spirometer and by RIP were qualitati­
vely and quantitatively the same» and, as a consequence, 
the data were pooled. Table 2 presents the results, V'E 
increased significantly in BHR- as compared with con­
trol values before inhalation of histamine. The changes 
in V'E were not significant in BHR+. Breathing fre­
quency increased significantly in the whole group, BHR+ 
and BHR-. Although, on average, the control values of 
fR  were higher in BHR+, a further significant increase 
in fR  was found in response to histamine. In the whole 
group, BHR+ and BHR-, no significant changes were 
found in Vr between control and histamine values. Both 
control values of Vr and Vr after histamine were sig­
nificantly higher in BHR- as compared to BHR-k Mean± 
sem  increase in FRC after inhalation of histamine was
0,26±0.03 L, which was 8±1% of predicted. This incre­
ase in FRC was significantly (pcO.Ol) larger in BHR+ 
than in BHR-.
Figure 2a and b shows the relationships between 
AV'E and AFEV l in response to histamine and between 
À V'E and the histamine concentration applied, respec­
tively. Results are presented separately for BHR+ and 
BHR-. A significant correlation was found for the rela­
tionship between A V e and AFEVl for BHR+ (n=-0.319; 
p<0.05) and for the whole group (r=-0.273; p<0.05), but 
not for BHR-. Thus, it appeared that the subjects with 
the largest decrease in V'E showed a relatively large de­
crease in FEVl. No significant relationship was found 
between À V'E and the histamine concentration applied.
Discussion
The changes in V'E, fR  and Vr were not uniform; com­
parable numbers of subjects responded with increases 
(n=33) and decreases (n=30) in V'E. F o r / r , 40 subjects 
responded with an increase and 23 with a decrease; and 
for Vr, these numbers were 26 and 37, respectively. 
These results are in agreement with the observations of 
Stromberg  and G u sta fsso n  [13], who found that 50% 
of their subjects responded to histamine with an incre­
ase in V'E whereas, in the other 50% V'E was unchanged 
or tended to decrease.
The use of a mouthpiece and noseclip may be criti­
cized. Effects of a mouthpiece on breathing pattern have 
been described in the literature but conclusions are not 
consistent [3], In the present study, we have evaluated 
the effects of inhalation of histamine on respiratory vari­
ables. Values after histamine were compared to control 
values; Le. before the start of histamine nebulization. 
Thus, baseline values were obtained after subjects had 
been connected to the mouthpiece and the nose had 
been clipped. Hence, the differences in breathing pat­
tern found in response to histamine cannot be attributed 
to an effect of the mouthpiece or noseclip. It has recent­
ly been reported that ventilatory responses (Le. V'E) to 
inhaled histamine, measured by RIP, were diminished 
when breathing through a mouthpiece whilst wearing a 
noseclip [13]. All of our subjects breathed through a 
mouthpiece with the nose clipped. This might explain 
why we found a considerable number of ventilatory 
nonresponders. If changes in breathing pattern induced 
by inhalation of histamine are masked by an effect of
the mouthpiece and noseclip, responses in our study 
may be underestimated.
Histamine may stimulate RARs in two ways: mechan­
ically (by histamine-induced bronchoconstriction) and 
chemically. In our previous studies in cats [20, 21], we 
observed that stimulation of RARs either by negative 
airway pressure or by administration of histamine led 
to an increase in f R . We think, therefore, that histamine- 
induced increases in f R  seen in the present study (table 
2) were due, at least in part, to a vagal reflex in which 
RARs are involved.
In the subjects who were BHR+, the response of FRC 
on histamine was larger than in normal subjects (table 
2). This can be attributed to the more pronounced air­
flow limitation and the possible presence of end-tidal 
inspiratory activity during increased activity of RARs 
[20, 21]. An increase in FRC may limit an increase in 
Vr or even cause a decrease in Vr with a concomitant 
decrease in V'E. Moreover, the increased airway resist­
ance after inhalation of histamine may cause a decrease 
in Vr and V'E in subjects with large decreases in FEVl. 
This may explain: 1) why we found that V'E was neg­
atively correlated to AFEVl (fig. 2), Le. V'E decreased 
especially in subjects with large decreases in FEVl 
(BHR+); and 2) why the increase in V'E after histamine 
was not significant in subjects who were hyperrespon- 
sive (table 2), A combination of histamine-induced 
increases in /R  and bronchoconstriction-induced reduc­
tions in Vr may explain why, in several subjects (n=24), 
opposite responses were seen, Le. f R  increased whilst 
simultaneously Vr decreased.
We conclude that, in general, respiratory responses to 
inhaled histamine are not predictable. Respiratory fre­
quency increased significantly both in hyperresponsive 
and nonhyperresponsive subjects. The concomitant in­
crease in minute ventilation, however, was significant 
in nonhyperresponsive subjects but not in hyperrespon­
sive subjects. These findings may be interpreted to indi­
cate that different mechanisms with opposite effects 
may be operating simultaneously, e.g. excitation of cen­
tral inspiratory activity by stimulation of rapidly-adap- 
ting pulmonary stretch receptors, which will promote 
increases in respiratory frequency, tidal volume and 
minute ventilation, and bronchoconstriction with increa­
sed airway resistance, which will promote decreases in 
these parameters. As a consequence, depending on the 
net result of these opposite contributions to, for instance 
minute ventilation, administration of histamine will cause 
an increase in minute ventilation in one subject and a 
decrease in another subject.
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